In this report, the United States CD28(Antibody) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of CD28(Antibody) in these regions, from 2012 to 2022 (forecast).
United States CD28(Antibody) market competition by top manufacturers/players, with CD28(Antibody) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbexa Ltd(UK)
Aviva Systems Biology Corporation(US)
Boster Biological Technology(US)
Biobyt(UK)
Bio-Rad(US)
Bioss Antibodies(US)
BioLegend(US)
Lifespan Biosciences(US)
ProteoGenix(FR)
Novus Biologicals(US)
ProSci(US)
ProteoGenix(FR)
R&D Systems(US)
Thermo Fisher Scientific(US)
USBiological(US)
BethylLaboratories(US)
Genetex(US)
Rockland(US)
SouthernBiotech(US)
St John's Laboratory Ltd(UK)
Atlas Antibodies(SE)
BioVision(US)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Above 90%
Above 95%
Above 99%
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States CD28(Antibody) Market Report 2017
1 CD28(Antibody) Overview
1.1 Product Overview and Scope of CD28(Antibody)
1.2 Classification of CD28(Antibody) by Product Category
1.2.1 United States CD28(Antibody) Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States CD28(Antibody) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Above 90%
1.2.4 Above 95%
1.2.5 Above 99%
1.2.6 Others
1.3 United States CD28(Antibody) Market by Application/End Users
1.3.1 United States CD28(Antibody) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Biopharmaceutical Companies
1.3.3 Hospitals
1.3.4 Bioscience Research Institutions
1.3.5 Others
1.4 United States CD28(Antibody) Market by Region
1.4.1 United States CD28(Antibody) Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West CD28(Antibody) Status and Prospect (2012-2022)
1.4.3 Southwest CD28(Antibody) Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic CD28(Antibody) Status and Prospect (2012-2022)
1.4.5 New England CD28(Antibody) Status and Prospect (2012-2022)
1.4.6 The South CD28(Antibody) Status and Prospect (2012-2022)
1.4.7 The Midwest CD28(Antibody) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of CD28(Antibody) (2012-2022)
1.5.1 United States CD28(Antibody) Sales and Growth Rate (2012-2022)
1.5.2 United States CD28(Antibody) Revenue and Growth Rate (2012-2022)
2 United States CD28(Antibody) Market Competition by Players/Suppliers
2.1 United States CD28(Antibody) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States CD28(Antibody) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States CD28(Antibody) Average Price by Players/Suppliers (2012-2017)
2.4 United States CD28(Antibody) Market Competitive Situation and Trends
2.4.1 United States CD28(Antibody) Market Concentration Rate
2.4.2 United States CD28(Antibody) Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers CD28(Antibody) Manufacturing Base Distribution, Sales Area, Product Type
3 United States CD28(Antibody) Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States CD28(Antibody) Sales and Market Share by Region (2012-2017)
3.2 United States CD28(Antibody) Revenue and Market Share by Region (2012-2017)
3.3 United States CD28(Antibody) Price by Region (2012-2017)
4 United States CD28(Antibody) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States CD28(Antibody) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States CD28(Antibody) Revenue and Market Share by Type (2012-2017)
4.3 United States CD28(Antibody) Price by Type (2012-2017)
4.4 United States CD28(Antibody) Sales Growth Rate by Type (2012-2017)
5 United States CD28(Antibody) Sales (Volume) by Application (2012-2017)
5.1 United States CD28(Antibody) Sales and Market Share by Application (2012-2017)
5.2 United States CD28(Antibody) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States CD28(Antibody) Players/Suppliers Profiles and Sales Data
6.1 Abbexa Ltd(UK)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 CD28(Antibody) Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbexa Ltd(UK) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Aviva Systems Biology Corporation(US)
6.2.2 CD28(Antibody) Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Aviva Systems Biology Corporation(US) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Boster Biological Technology(US)
6.3.2 CD28(Antibody) Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Boster Biological Technology(US) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Biobyt(UK)
6.4.2 CD28(Antibody) Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Biobyt(UK) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bio-Rad(US)
6.5.2 CD28(Antibody) Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bio-Rad(US) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bioss Antibodies(US)
6.6.2 CD28(Antibody) Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bioss Antibodies(US) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 BioLegend(US)
6.7.2 CD28(Antibody) Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 BioLegend(US) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Lifespan Biosciences(US)
6.8.2 CD28(Antibody) Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Lifespan Biosciences(US) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 ProteoGenix(FR)
6.9.2 CD28(Antibody) Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 ProteoGenix(FR) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novus Biologicals(US)
6.10.2 CD28(Antibody) Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novus Biologicals(US) CD28(Antibody) Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 ProSci(US)
6.12 ProteoGenix(FR)
6.13 R&D Systems(US)
6.14 Thermo Fisher Scientific(US)
6.15 USBiological(US)
6.16 BethylLaboratories(US)
6.17 Genetex(US)
6.18 Rockland(US)
6.19 SouthernBiotech(US)
6.20 St John's Laboratory Ltd(UK)
6.21 Atlas Antibodies(SE)
6.22 BioVision(US)
7 CD28(Antibody) Manufacturing Cost Analysis
7.1 CD28(Antibody) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of CD28(Antibody)
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 CD28(Antibody) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of CD28(Antibody) Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States CD28(Antibody) Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States CD28(Antibody) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States CD28(Antibody) Sales Volume Forecast by Type (2017-2022)
11.3 United States CD28(Antibody) Sales Volume Forecast by Application (2017-2022)
11.4 United States CD28(Antibody) Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of CD28(Antibody)
Figure United States CD28(Antibody) Market Size (MT) by Type (2012-2022)
Figure United States CD28(Antibody) Sales Volume Market Share by Type (Product Category) in 2016
Figure Above 90% Product Picture
Figure Above 95% Product Picture
Figure Above 99% Product Picture
Figure Others Product Picture
Figure United States CD28(Antibody) Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of CD28(Antibody) by Application in 2016
Figure Biopharmaceutical Companies Examples
Table Key Downstream Customer in Biopharmaceutical Companies
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Bioscience Research Institutions Examples
Table Key Downstream Customer in Bioscience Research Institutions
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States CD28(Antibody) Market Size (Million USD) by Region (2012-2022)
Figure The West CD28(Antibody) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest CD28(Antibody) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic CD28(Antibody) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England CD28(Antibody) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US CD28(Antibody) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest CD28(Antibody) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States CD28(Antibody) Sales (MT) and Growth Rate (2012-2022)
Figure United States CD28(Antibody) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States CD28(Antibody) Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States CD28(Antibody) Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States CD28(Antibody) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States CD28(Antibody) Sales Share by Players/Suppliers
Figure 2017 United States CD28(Antibody) Sales Share by Players/Suppliers
Figure United States CD28(Antibody) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States CD28(Antibody) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States CD28(Antibody) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States CD28(Antibody) Revenue Share by Players/Suppliers
Figure 2017 United States CD28(Antibody) Revenue Share by Players/Suppliers
Table United States Market CD28(Antibody) Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market CD28(Antibody) Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States CD28(Antibody) Market Share of Top 3 Players/Suppliers
Figure United States CD28(Antibody) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers CD28(Antibody) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers CD28(Antibody) Product Category
Table United States CD28(Antibody) Sales (MT) by Region (2012-2017)
Table United States CD28(Antibody) Sales Share by Region (2012-2017)
Figure United States CD28(Antibody) Sales Share by Region (2012-2017)
Figure United States CD28(Antibody) Sales Market Share by Region in 2016
Table United States CD28(Antibody) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States CD28(Antibody) Revenue Share by Region (2012-2017)
Figure United States CD28(Antibody) Revenue Market Share by Region (2012-2017)
Figure United States CD28(Antibody) Revenue Market Share by Region in 2016
Table United States CD28(Antibody) Price (USD/Kg) by Region (2012-2017)
Table United States CD28(Antibody) Sales (MT) by Type (2012-2017)
Table United States CD28(Antibody) Sales Share by Type (2012-2017)
Figure United States CD28(Antibody) Sales Share by Type (2012-2017)
Figure United States CD28(Antibody) Sales Market Share by Type in 2016
Table United States CD28(Antibody) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States CD28(Antibody) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of CD28(Antibody) by Type (2012-2017)
Figure Revenue Market Share of CD28(Antibody) by Type in 2016
Table United States CD28(Antibody) Price (USD/Kg) by Types (2012-2017)
Figure United States CD28(Antibody) Sales Growth Rate by Type (2012-2017)
Table United States CD28(Antibody) Sales (MT) by Application (2012-2017)
Table United States CD28(Antibody) Sales Market Share by Application (2012-2017)
Figure United States CD28(Antibody) Sales Market Share by Application (2012-2017)
Figure United States CD28(Antibody) Sales Market Share by Application in 2016
Table United States CD28(Antibody) Sales Growth Rate by Application (2012-2017)
Figure United States CD28(Antibody) Sales Growth Rate by Application (2012-2017)
Table Abbexa Ltd(UK) Basic Information List
Table Abbexa Ltd(UK) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abbexa Ltd(UK) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure Abbexa Ltd(UK) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure Abbexa Ltd(UK) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table Aviva Systems Biology Corporation(US) Basic Information List
Table Aviva Systems Biology Corporation(US) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Aviva Systems Biology Corporation(US) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure Aviva Systems Biology Corporation(US) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure Aviva Systems Biology Corporation(US) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table Boster Biological Technology(US) Basic Information List
Table Boster Biological Technology(US) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Boster Biological Technology(US) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure Boster Biological Technology(US) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure Boster Biological Technology(US) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table Biobyt(UK) Basic Information List
Table Biobyt(UK) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biobyt(UK) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure Biobyt(UK) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure Biobyt(UK) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table Bio-Rad(US) Basic Information List
Table Bio-Rad(US) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bio-Rad(US) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure Bio-Rad(US) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure Bio-Rad(US) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table Bioss Antibodies(US) Basic Information List
Table Bioss Antibodies(US) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bioss Antibodies(US) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure Bioss Antibodies(US) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure Bioss Antibodies(US) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table BioLegend(US) Basic Information List
Table BioLegend(US) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BioLegend(US) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure BioLegend(US) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure BioLegend(US) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table Lifespan Biosciences(US) Basic Information List
Table Lifespan Biosciences(US) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Lifespan Biosciences(US) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure Lifespan Biosciences(US) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure Lifespan Biosciences(US) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table ProteoGenix(FR) Basic Information List
Table ProteoGenix(FR) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ProteoGenix(FR) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure ProteoGenix(FR) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure ProteoGenix(FR) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table Novus Biologicals(US) Basic Information List
Table Novus Biologicals(US) CD28(Antibody) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novus Biologicals(US) CD28(Antibody) Sales Growth Rate (2012-2017)
Figure Novus Biologicals(US) CD28(Antibody) Sales Market Share in United States (2012-2017)
Figure Novus Biologicals(US) CD28(Antibody) Revenue Market Share in United States (2012-2017)
Table ProSci(US) Basic Information List
Table ProteoGenix(FR) Basic Information List
Table R&D Systems(US) Basic Information List
Table Thermo Fisher Scientific(US) Basic Information List
Table USBiological(US) Basic Information List
Table BethylLaboratories(US) Basic Information List
Table Genetex(US) Basic Information List
Table Rockland(US) Basic Information List
Table SouthernBiotech(US) Basic Information List
Table St John's Laboratory Ltd(UK) Basic Information List
Table Atlas Antibodies(SE) Basic Information List
Table BioVision(US) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of CD28(Antibody)
Figure Manufacturing Process Analysis of CD28(Antibody)
Figure CD28(Antibody) Industrial Chain Analysis
Table Raw Materials Sources of CD28(Antibody) Major Players/Suppliers in 2016
Table Major Buyers of CD28(Antibody)
Table Distributors/Traders List
Figure United States CD28(Antibody) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States CD28(Antibody) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States CD28(Antibody) Price (USD/Kg) Trend Forecast (2017-2022)
Table United States CD28(Antibody) Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States CD28(Antibody) Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States CD28(Antibody) Sales Volume (MT) Forecast by Type in 2022
Table United States CD28(Antibody) Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States CD28(Antibody) Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States CD28(Antibody) Sales Volume (MT) Forecast by Application in 2022
Table United States CD28(Antibody) Sales Volume (MT) Forecast by Region (2017-2022)
Table United States CD28(Antibody) Sales Volume Share Forecast by Region (2017-2022)
Figure United States CD28(Antibody) Sales Volume Share Forecast by Region (2017-2022)
Figure United States CD28(Antibody) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
